title: Proniosomal formulation of curcumin having anti-inflammatory and anti-arthritic activity in different experimental animal models.
abstract: Curcumin, the active ingredient of the spice turmeric, has a long history as an herbal remedy for a variety of diseases. Transdermal drug delivery has been recognized as an alternative route to oral delivery. Proniosomes offer a versatile vesicle delivery concept with the potential for drug delivery via the transdermal route. In this study, different proniosomal gel bases were prepared by the ether injection method, using Span 60 and Span 80, Tween 20, cholesterol, and formulation PA2. They were characterized by scanning electron microscopy, revealing vesicular structures, and assessed for stability and effect on in vitro skin permeation using rat skin. Anti-inflammatory and anti-arthritic effects of formulation PA2 and PB1 were compared with a standard market product containing indomethacin. The effect of formulation PA2 and PB1 was evaluated for acute inflammation in carrageenan induced rat paw edema and for chronic inflammation in complete Freud's adjuvant (CFA) induced arthritis in rats. Further histopathological and radiographic evaluation was performed. The investigated curcumin loaded proniosomal formula proved to be non-irritant, non-toxic, but had lower anti-inflammatory and anti-arthritic effects than the marketed indomethacin products.
authors.affiliation: Institute of Pharmacy NIMS University, Jaipur, Rajasthan, India. kapil5november@gmail.com
authors.forename: K
authors.initials: K
authors.lastname: Kumar
authors.forename: A K
authors.initials: AK
authors.lastname: Rai
mesh_terms: D000279:Administration, Cutaneous; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D001169:Arthritis, Experimental / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology; D001772:Blood Cell Count; D001835:Body Weight / Q000187:drug effects; D002626:Chemistry, Pharmaceutical; D002784:Cholesterol / Q000737:chemistry; D003474:Curcumin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D004337:Drug Carriers; D004355:Drug Stability; D005079:Excipients / Q000737:chemistry; D005260:Female; D005528:Foot / Q000473:pathology; D007509:Irritants; D008081:Liposomes; D008297:Male; D008855:Microscopy, Electron, Scanning; D011859:Radiography; D051381:Rats; D017208:Rats, Wistar; D012869:Skin Absorption
chemical_list: D000893:Anti-Inflammatory Agents; D004337:Drug Carriers; D005079:Excipients; D007509:Irritants; D008081:Liposomes; D002784:Cholesterol; D003474:Curcumin